BioPharma Drive: Drug Pricing
SEPTEMBER 5, 2023
The FDA-approved therapy, called Palforzia, was little used, leading Nestle to abandon a business it had secured in a $2.6 billion deal three years ago.
Drugs.com
SEPTEMBER 8, 2023
FRIDAY, Sept. 8, 2023 -- Receiving an organ transplant can be a nerve-wracking, if lifesaving, affair, said Dr. Joaquin Brieva, a kidney transplant recipient. “Within two days of my transplant, my kidney function was back to normal, but then.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
SEPTEMBER 8, 2023
Researchers who created a soft robot that could navigate simple mazes without human or computer direction have now built on that work, creating a 'brainless' soft robot that can navigate more complex and dynamic environments.
Covalent Modifiers
SEPTEMBER 3, 2023
Jason G. Kettle, Sharan K. Bagal, Derek Barratt, Michael S. Bodnarchuk, Scott Boyd, Erin Braybrooke, Jason Breed, Doyle J. Cassar, Sabina Cosulich, Michael Davies, Nichola L. Davies, Chao Deng, Andrew Eatherton, Laura Evans, Lyman J. Feron, Shaun Fillery, Emma S. Gleave, Frederick W. Goldberg, Miguel A. Cortés González, Carine Guerot, Afreen Haider, Stephanie Harlfinger, Rachel Howells, Anne Jackson, Peter Johnström, Paul D.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
BioPharma Drive: Drug Pricing
SEPTEMBER 5, 2023
The announcement marks progress for Beam after trial delays, and is the first time in the U.S. that a patient has received a base editing treatment.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
SEPTEMBER 7, 2023
Researchers have successfully created chimeric embryos containing a combination of human and pig cells. When transferred into surrogate pig mothers, the developing humanized kidneys had normal structure and tubule formation after 28 days. This is the first time that scientists have been able to grow a solid humanized organ inside another species, though previous studies have used similar methods to generate human tissues such as blood or skeletal muscle in pigs.
Covalent Modifiers
SEPTEMBER 2, 2023
Pasquale A. Morese, Nahoum Anthony, Michael Bodnarchuk, Claire Jennings, Mathew P. Martin, Richard A. Noble, Nicole Phillips, Huw D. Thomas, Lan Z. Wang, Andrew Lister, Martin E. M. Noble, Richard A. Ward, Stephen R. Wedge, Hannah L. Stewart, and Michael J. Waring Journal of Medicinal Chemistry 2023 DOI: 10.1021/acs.jmedchem.3c00845 A major drawback of cytotoxic chemotherapy is the lack of selectivity toward noncancerous cells.
BioPharma Drive: Drug Pricing
SEPTEMBER 6, 2023
Jane Grogan, an industry veteran who worked at Genentech for over 15 years, will take over the role starting Oct. 2. She’ll fill a seat that's lacked a permanent replacement since the departure of Al Sandrock.
Drugs.com
SEPTEMBER 7, 2023
THURSDAY, Sept. 7, 2023 -- The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Science Daily: Pharmacology News
SEPTEMBER 7, 2023
Crustaceans, insects and mushrooms are rich sources of the dietary fiber chitin, which activates the immune system and benefits metabolism, according to a new study in mice.
Covalent Modifiers
SEPTEMBER 7, 2023
Srinivasa P. S. Rao et al. Science 2023 , 380, 1349-1356 DOI: 10.1126/science.adh0614 Millions who live in Latin America and sub-Saharan Africa are at risk of trypanosomatid infections, which cause Chagas disease and human African trypanosomiasis (HAT). Improved HAT treatments are available, but Chagas disease therapies rely on two nitroheterocycles, which suffer from lengthy drug regimens and safety concerns that cause frequent treatment discontinuation.
BioPharma Drive: Drug Pricing
SEPTEMBER 8, 2023
Shape uses machine learning and high throughput screening to identify new AAV capsids in ways the company’s CEO compares to the generative AI tools Midjourney and DALLE-2.
Drugs.com
SEPTEMBER 8, 2023
FRIDAY, Sept. 8, 2023 -- Therapies based on a hormone people make while exercising may be the next frontier in treating Alzheimer’s disease, according to a new study. Researchers have found that the exercise-induced hormone irisin may reduce both.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
SEPTEMBER 7, 2023
An international consortium of scientists is using an unprecedentedly large database of canine DNA to take an unbiased look at how our furry friends evolved into the various breeds we know and love.
Broad Institute
SEPTEMBER 6, 2023
New research alliance with Novo Nordisk to identify therapeutic targets for type 2 diabetes and cardiometabolic diseases By Allessandra DiCorato September 6, 2023 Breadcrumb Home New research alliance with Novo Nordisk to identify therapeutic targets for type 2 diabetes and cardiometabolic diseases The collaboration aims to identify disease-modifying interventions, with the goal of improving standards of care for people living with type 2 diabetes and cardiac fibrosis By Broad Communications Sep
BioPharma Drive: Drug Pricing
SEPTEMBER 8, 2023
Worth up to $840 million, the collaboration will give Alexion access to Verge Genomics’ platform, which uses human tissue data to find drug targets for diseases that degrade the nerve system.
Drugs.com
SEPTEMBER 8, 2023
FRIDAY, Sept. 8, 2023 -- New Swedish research suggests that up to 5% of 70-year-olds have glaucoma, and half of those diagnosed didn't even know they had the disease. “Of those who were diagnosed with glaucoma via the study, 15 people -- or 2.7%.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Science Daily: Pharmacology News
SEPTEMBER 5, 2023
The immense bubble is 820 million light years from Earth and believed to be a fossil-like remnant of the birth of the universe.
addgene Blog
SEPTEMBER 5, 2023
We excited to announce the fourth edition of our popular eBook, Plasmids 101, is now available!
BioPharma Drive: Drug Pricing
SEPTEMBER 8, 2023
The PASTEUR Act could be heading for another legislative blow, but advocates say they see a future for the mechanism to fund research into antimicrobial resistance.
Drugs.com
SEPTEMBER 7, 2023
THURSDAY, Sept. 7, 2023 -- Emergency room visits for injuries related to driving under the influence of cannabis skyrocketed in Canada after the drug was legalized there, a new study reports. In October 2018, Canada became the second country to.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Science Daily: Pharmacology News
SEPTEMBER 7, 2023
Antarctica's vast ice masses seem far away, yet they store enough water to raise global sea levels by several meters. A team of experts has now provided the first systematic stability inspection of the ice sheet's current state. Their diagnosis: While they found no indication of irreversible, self-reinforcing retreat of the ice sheet in West Antarctica yet, global warming to date could already be enough to trigger the slow but certain loss of ice over the next hundreds to thousands of years.
keypoint
SEPTEMBER 6, 2023
Established in 2009, Keystone Symposia’s Fellows Program has become a premier professional advancement opportunity for rising scientists from diverse backgrounds. This unique one-year fellowship provides early-stage investigators (ESIs) (within 6 years of starting an independent research program) from underrepresented (UR) and other disadvantaged backgrounds with the support, skills and networking opportunities they need to successfully pursue research careers and leadership roles in academic, i
BioPharma Drive: Drug Pricing
SEPTEMBER 7, 2023
Fresh off a Series C fundraise, Kriya has acquired the privately held Tramotane Therapeutics and its preclinical candidate for the widely prevalent liver disease.
Drugs.com
SEPTEMBER 7, 2023
THURSDAY, Sept. 7, 2023 -- Respiratory syncytial virus (RSV) is a common viral infection that affects people of all ages, with infants and older adults being particularly vulnerable to severe complications. Preventing the spread of RSV requires a.
Science Daily: Pharmacology News
SEPTEMBER 4, 2023
The Qing Dynasty in China, after over 250 years, crumbled in 1912. An international research team has pinpointed key reasons behind the collapse, revealing parallels to modern instability and offering vital lessons for the future.
KIF1A
SEPTEMBER 2, 2023
#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. 2023 KAND Family & Scientific Engagement Conference Wrap-up A happy Labor Day weekend to our readers in the US!
BioPharma Drive: Drug Pricing
SEPTEMBER 6, 2023
The decision is the latest in a series of setbacks for the Actelion spinout and ends a lucrative partnership that began in 2017.
Drugs.com
SEPTEMBER 7, 2023
THURSDAY, Sept. 7, 2023 -- A new test detects a type of cervical cancer often missed by a standard Pap test, providing an important advance in detection. The test was developed by scientists at Montefiore Einstein Cancer Center in New York.
Expert insights. Personalized for you.
321 
Let's personalize your content